• Skip to main content
Search
  • Home
  • Services
      • Behavioral Health
      • Bloodless Medicine
      • Brain & Spine
      • Cancer Care
      • Ear, Nose and Throat
      • Emergency Care
      • Senior Health
      • Heart & Vascular Care
      • Home Health Care
      • Immediate Care
      • Medical Imaging
      • Minimally Invasive Surgery
      • Orthopedics
      • Pregnancy & Childbirth
      • Primary Care
      • Rehabilitation Services
      • Weight Loss Surgery
      • Wound Healing & Care
      • Women's Health
  • Doctors
      • Find a Primary Care Doctor
      • Find a Doctor
      • Physician Referral
      • Practices:

        Baptist Primary Care
      • Baptist AgeWell
      • Baptist Behavioral Health
      • Baptist Endocrinology
      • Baptist ENT Specialists
      • Baptist Heart Specialists
      • Baptist Infectious Diseases
      • Baptist MD Anderson Cancer Physicians
      • Baptist Neurology
      • Baptist Pediatrics
      • Baptist Pulmonary Specialists (Nassau)
      • Baptist Rheumatology
      • Baptist Urology Group (Nassau)
      • Jacksonville Orthopaedic Institute
      • Lyerly Neurosurgery
  • Locations
    • Our Hospitals:

      • Baptist Medical Center Jacksonville
      • Baptist Medical Center South
      • Baptist Medical Center Beaches
      • Baptist Medical Center Nassau
      • Baptist Heart Hospital
      • Wolfson Children's Hospital

      Emergency Rooms (ER):

      • All ER Locations

      Imaging:

      • By Location

      • Imaging Center Locations
      • By Service

      • MRI
      • Bone Density
      • Screening Mammography
      • Diagnostic Mammography
      • Ultrasound
      • Vascular Ultrasound
      • CT Scan
      • PET Scan
      • Nuclear Medicine
      • X-Ray

      Urgent Care Locations:

      • Baptist Health Clinics at Walgreens
      • CareSpot Urgent Care

      Outpatient Locations:

      • AgeWell Center for Senior Health
      • Baptist Clay Medical Campus
      • Baptist MD Anderson Cancer Center
      • Baptist Neurodiagnostic Center
      • Baptist North Medical Campus
      • Heart and Vascular Testing Centers
      • Hill Breast Center
      • Infusion Center
      • Pharmacy
      • Rehabilitation Centers
      • Robotic Spine Surgery
      • Sleep Centers
      • Stroke and Cerebrovascular Center
      • Surgery Centers
      • Wound Care

      Health & Wellness:

      • 4her Wellness Resources for Women
      • JCA Wellness Connexion
      • Y Healthy Living Centers
  • Patient Info
      • Billing & Insurance Information
      • Insurance Plans Accepted
      • Cost Estimate Request
      • Financial Assistance Program
      • My Baptist Connect (Patient Portal)
      • Medical Records
      • Classes and Events
      • Clinical Trials
      • Tell Us What You Think
  • Health Library
      • Diseases and Conditions
      • Symptoms
      • Tests
      • Surgeries and Procedures
      • Injuries
      • Nutrition
      • Poison
      • Drug Information
      • Drug Images
      • Health News
      • Video Library
  • About Us
      • Administration
      • Awards & Honors
      • Careers
      • Provider Opportunities
      • Baptist MD Anderson Provider Opportunities
      • Spiritual Care
      • Social Responsibility
      • Community Health Needs Assessment (CHNA)
      • Corporate Wellness (PATH)
      • Volunteering
      • Newsroom
  • Juice
      • Health News Overview:

      • Aging Well
      • Brain, Spine & Nerve
      • Cancer
      • Child Health
      • Community Health
      • Diabetes
      • Ear, Nose & Throat
      • Heart & Vascular
      • Lungs, Breathing & Sleep
      • Mental Health
      • Orthopedics, Bones & Muscles
      • Pregnancy & Childbirth
      • Primary Care
      • Wellness
      • Women's Health
      • Men's Health
  1. Home
  2. Health Library
  3. Health News
  4. Major Study Gives Women More Guidance on Hormone Therapy During Menopause

Major Study Gives Women More Guidance on Hormone Therapy During Menopause

THURSDAY, Aug. 29, 2019 (HealthDay News) -- Women who receive hormone therapy to help ease menopausal symptoms have an increased risk of breast cancer, which can persist long after they stop the therapy, a new study confirms.

The new review -- which included data from 58 studies involving nearly 109,000 women from around the world -- is the latest chapter in the ongoing story of these hormone therapies.

"Since the Women's Health Initiative [study] identified in 2002 that women who took hormone replacement therapy were at an increased risk for the development of breast cancer, we have seen a marked decline in their use," noted Dr. Lauren Cassell, a breast surgeon at Lenox Hill Hospital in New York City. She wasn't involved in the new report.

"Patients who were on hormone replacement went off them [after the 2002 study], and physicians were more cautious in prescribing them," Cassell said.

The new report, published Aug. 29 in The Lancet, "again reinforces that known increased risk, but more importantly, it identifies that the risk persists even after the therapy is stopped, and is affected by the length of time that the patient takes hormone replacement," Cassell said.

The new analysis was performed by a global team of experts known as the Collaborative Group on Hormonal Factors in Breast Cancer. They pored over data from 58 studies conducted worldwide between 1992 and 2018. These studies included nearly 109,000 women with breast cancer, with an average age of 65 at diagnosis.

Half of the women had received hormone therapy for menopause, the researchers noted. The average age at menopause was 50 and the average age at starting hormone therapy was also 50. Women took hormone therapy for an average of 10 years, in current users, and for seven years in past users, the team said.

For women of average weight living in Western countries who have never used hormone therapy, the average risk of developing breast cancer between ages 50 to 69 was about 6.3 per 100 women, according to the study.

However, the risk rose for women who received hormone therapy, and the formulation used seemed key to an uptick in risk.

For example, for women who took treatments involving estrogen plus daily progestogen for five years, the rate of breast cancer was 8.3 per every 100 women. It was slightly lower for women taking estrogen plus intermittent progestogen -- 7.7 per 100.

The rate was lower -- but still elevated -- for women who used an estrogen-only therapy: 6.8 cases per 100, the findings showed.

Duration of use mattered, as well. The rise in breast cancer risk was about twice as high for women who used hormone therapy for 10 years rather than five years, the study found.

Conversely, there was little increased risk of breast cancer after using any form of hormone therapy for less than a year, the researchers said.

One major finding was just how long hormone therapies left their mark for women who used the treatment for five years; any elevation in breast cancer risk didn't fully subside until 15 years after stopping the therapy.

The findings suggest that all types of hormone therapy for menopause -- with the exception of topical vaginal estrogens -- are associated with an increased risk of breast cancer, the study authors said.

"Our new findings indicate that some increased risk persists even after stopping use of menopausal hormone therapy," study co-author Valerie Beral, a professor at the University of Oxford in England, said in a journal news release.

The use of hormone therapy for menopause rose sharply in the 1990s, fell by half in the early 2000s and stabilized in the 2010s. Currently, there are about 12 million users in Western countries -- about 6 million in North America and 6 million in Europe.

Ten years of use was once common, but about five years of use is now more likely, the researchers said.

Dr. Alice Police directs breast surgery at Northwell Health Cancer Institute in Sleepy Hollow, N.Y. Looking over the study, she said that as time goes by, research like this is giving women better guidelines on what is or is not safe when it comes to hormonal therapies.

For example, "we now know that topical vaginal creams do not increase the risk of breast cancer as they mostly work locally and absorption is minimal. This is great news for many women who depend on these therapies to prevent UTIs [urinary tract infections] and vaginal dryness," Police said.

"We also know which medications, in what combinations, are the most dangerous," she added. "For example, estrogen alone is safer than estrogen and progesterone together."

For her part, Cassell said that, going forward, "oral hormone replacement therapy should be prescribed judiciously for patients who are having intolerable symptoms of menopause and understand the increased risk for breast cancer."

That means, "the use of progesterone should be minimized and the length of the hormone replacement should be as short as possible," Cassell said.

More information

The U.S. National Cancer Institute has more on menopausal hormone therapy and cancer.

SOURCES: Alice Police, M.D., Westchester regional director of breast surgery, Northwell Health Cancer Institute, Sleepy Hollow, N.Y.; Lauren Cassell, M.D., chief, breast surgery, Lenox Hill Hospital, New York City; The Lancet, news release, Aug. 29, 2019

Daily Health and Medical News

  • Babies May 'See' Light While in the Womb
    December 03, 2019

  • Uncontrolled Asthma a Danger to Pregnant Women, Babies
    December 03, 2019

  • Are E-Scooters a Quick Ticket to the ER?
    December 03, 2019

  • Taking Several Prescription Drugs May Trigger Serious Side Effects
    December 03, 2019

  • AHA News: Vegan Diet May Decrease Heart Disease, Stroke Risk in African Americans
    December 03, 2019

© Copyright 2019 | All Rights Reserved

If you speak another language, assistance services
free of charge, are available to you.

Baptist Health Facebook Baptist Health Twitter Baptist Health on LinkedIn Baptist Health on Instagram Baptist Health on Youtube
Physician Login | Application Login | Employee Login
Quality Measures | Privacy | Non-Discrimination | Comments | Site Map